AssetMark Inc
HAE icon

AssetMark Inc’s Haemonetics HAE Stock Holding History

AssetMark Inc’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$600 Hold
8
– – ﹤0.01% 3261
2026
Q1 		$451 Buy
8
+3
+60% +$195 ﹤0.01% 3202
2025
Q4 		$401 Hold
5
– – ﹤0.01% 3139
2025
Q3 		$244 Sell
5
-5
-50% -$309 ﹤0.01% 3039
2025
Q2 		$746 Buy
10
+8
+400% +$530 ﹤0.01% 2670
2025
Q1 		$127 Sell
2
-2
-50% -$136 ﹤0.01% 2554
2024
Q4 		$312 Buy
+4
New +$321 ﹤0.01% 2434
2023
Q4 		– Sell
-1
Closed -$90 – 1917
2023
Q3 		$90 Buy
+1
New +$89 ﹤0.01% 1704
2021
Q2 		– Sell
-8
Closed -$1K – 1410
2021
Q1 		$1K Sell
8
-343
-98% -$42.4K ﹤0.01% 1251
2020
Q4 		$42K Hold
351
– – ﹤0.01% 737
2020
Q3 		$31K Buy
351
+1
+0.3% +$87 ﹤0.01% 759
2020
Q2 		$31K Buy
350
+342
+4,275% +$34.5K ﹤0.01% 732
2020
Q1 		$1K Sell
8
-6
-43% -$651 ﹤0.01% 1256
2019
Q4 		$2K Hold
14
– – ﹤0.01% 1236
2019
Q3 		$2K Sell
14
-24
-63% -$3.05K ﹤0.01% 1164
2019
Q2 		$5K Buy
38
+11
+41% +$1.08K ﹤0.01% 1056
2019
Q1 		$2K Sell
27
-3
-10% -$273 ﹤0.01% 1166
2018
Q4 		$3K Sell
30
-19
-39% -$2K ﹤0.01% 1158
2018
Q3 		$6K Sell
49
-7
-13% -$725 ﹤0.01% 1135
2018
Q2 		$5K Sell
56
-2
-3% -$169 ﹤0.01% 1161
2018
Q1 		$4K Sell
58
-25
-30% -$1.72K ﹤0.01% 1180
2017
Q4 		$5K Buy
+83
New +$4.37K ﹤0.01% 1242

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AssetMark Inc's HAE Position: Q2 2026 in Review

AssetMark Inc held its Haemonetics (HAE) position steady in Q2 2026 at 8 shares worth $600. The position accounts for ﹤0.01% of the portfolio, ranked #3261.

AssetMark Inc first reported a position in HAE in Q4 2017 and has held it in 22 quarters since. The position peaked at $42K in Q4 2020. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • AssetMark Inc held 8 shares of Haemonetics worth $600 as of Q2 2026.
  • AssetMark Inc left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #3261 holding.
  • AssetMark Inc first reported a position in Haemonetics in Q4 2017 and has held it in 22 quarters since.
  • AssetMark Inc's Haemonetics position peaked at $42K in Q4 2020.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.